Relative glucose metabolic rate higher in white matter in patients with schizophrenia

American Journal of Psychiatry

Volumn 164, Issue 7, 2007, Pages 1072-1081

  Buchsbaum, Monte S ^a   Buchsbaum, Bradley R ^b   Hazlett, Erin A ^b   Haznedar, M Mehmet ^b   Newmark, Randall ^b   Tang, Cheuk Y ^b   Hof, Patrick R ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; FEMALE; GLUCOSE ASSAY; GLUCOSE METABOLISM; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA; TASK PERFORMANCE; WHITE MATTER;

EID: 34547200425     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2007.164.7.1072     Document Type: Article

References (58)

1. Shenton ME, Dickey CC, Frumin M, McCarley RW: A review of MRI findings in schizophrenia. Schizophr Res 2001; 49:1-52
2. Benes FM: Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 2000; 31:251-269
3. Bunney WE, Bunney BG: Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res Brain Res Rev 2000; 31:138-146
4. Carlsson A: A paradigm shift in brain research. Science 2001; 294:1021-1024
5. Grace AA: Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Brain Res Rev 2000; 31330-341
6. Heimer L: Basal forebrain in the context of schizophrenia. Brain Res Brain Res Rev 2000; 31:205-235
7. Middleton FA, Strick PL: Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Brain Res Rev 2000; 31:236-250
8. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA: Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 2001; 98:4746-4751
9. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V: White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 2003; 60:443-456
10. Hof PR, Haroutunian V, Friedrich VL Jr, Byne W, Buitron C, Perl DP, Davis KL: Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 2003; 53:1075-1085
11. Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, Rachmanova V: Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 2001; 55:597-610
12. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI: Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 2004; 67:269-275
13. Vostrikov VM, Uranova NA, Rakhmanova VI, Orlovskaia DD: Lowered oligodendroglial cell density in the prefrontal cortex in schizophrenia. Zh Nevrol Psikhiatr Im S S Korsakova 2004; 104:47-51
14. 18F] fluorodeoxyglucose autoradiography study in the rat. Neuroimage 2002; 16:993-998
15. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28:897-916
16. Buchsbaum MS, Hazlett EA, Haznedar MM, Spiegel-Cohen J, Wei TC: Visualizing fronto-striatal circuitry and neuroleptic effects in schizophrenia. Acta Psychiatr Scand Suppl 1999; 395:129-137
17. Desco M, Gispert JD, Reig S, Sanz J, Pascau J, Sarramea F, Benito C, Santos A, Palomo T, Molina V: Cerebral metabolic patterns in chronic and recent-onset schizophrenia. Psychiatry Res 2003; 122:125-135
18. Andreasen N, Flaum M, Arndt S: The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992; 49:615-623
19. Oldfield RC: The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 1971; 9:97-113
20. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276
21. Byne W, Buchsbaum MS, Kemether E, Hazlett EA, Shinwari A, Mitropoulou V, Siever LJ: Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. Arch Gen Psychiatry 2001; 58:133-140
22. Hazlett E, Buchsbaum M, Byne W, Wei T-C, Spiegel-Cohen J, Geneve C, Kinderlehrer R, Haznedar M, Shihabuddin L, Siever L: Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry 1999; 156:1190-1199
23. Hazlett E, Buchsbaum M, Mohs R, Spiegel-Cohen J, Wei T-C, Azueta R, Haznedar M, Singer M, Shihabuddin L, Luu-Hisa C: Age-related shift in brain region allocation during successful memory performance. Neurobiol Aging 1998; 19:437-445
24. Delis D, Kramer J, Kaplan E, Ober B: The California Verbal Learning Test. New York, Psychological Corp, 1987
25. Baddeley A: Working memory. Science 1992; 255:556-559
26. Woods RP, Grafton ST, Watson JD, Sicotte NL, Mazziotta JC: Automated Image Registration, II. intersubject validation of linear and nonlinear models. J Comput Assist Tomogr 1998; 22:153-165
27. Zhang Y, Brady M, Smith S: Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001; 20:45-57
28. Woolrich MW, Behrens TE, Beckmann CF, Smith SM: Mixture models with adaptive spatial regularization for segmentation with an application to fMRI data. IEEE Trans Med Imaging 2005; 24:1-11
29. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9:357-381
30. Swerdlow NR, Koob GF: Dopamine, schizophrenia, mania, and depression: towards a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci 1987; 10:197-245
31. Wu JC, Siegel BV, Haier RJ, Buchsbaum MS: Testing the Swerdlow/Koob model of schizophrenia pathophysiology using positron emission tomography. Behav Brain Sci 1990; 13:169-170
32. Kessler RM, Clark, CM, Buchsbaum, MS, Holcomb H, Margolin RA, Cappeletti J, Channing M, Manning RG, van Kammen DP, King AC, Johnson J: Regional correlations in patterns of glucose use in patients with schizophrenia and normal subjects during mild pain stimulation, in Positron Emission Tomography of the Brain. Edited by Heiss WD, Phelps ME. Berlin, Springer-Verlag, 1983, pp 196-200
33. Katz M, Buchsbaum MS, Siegel BV, Wu J, Haier RJ, Bunney WE: Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology 1996; 33:1-11
34. Esik O, Emri M, Szakall S Jr, Herzog H, Safrany G, Lengyel E, Boer A, Liszkay G, Tron L, Lengyel Z, Repa I: PET identifies transitional metabolic change in the spinal cord following a subthreshold dose of irradiation. Pathol Oncol Res 2004; 10:42-46
35. Esik O, Emri M, Csornai M, Kasler M, Godeny M, Tron L: Radiation myelopathy with partial functional recovery: PET evidence of long-term increased metabolic activity of the spinal cord. J Neurol Sci 1999; 163:39-43
36. Lengyel Z, Reko G, Majtenyi K, Pisch J, Csornai M, Lesznyak J, Tron L, Esik O: Autopsy verifies demyelination and lack of vascular damage in partially reversible radiation myelopathy. Spinal Cord 2003; 41:577-585
37. Schiepers C, Van Hecke P, Vandenberghe R, Van Oostende S, Dupont P, Demaerel P, Bormans G, Carton H: Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis. Mult Scler 1997; 3:8-17
38. Mastronardi FG, Moscarello MA: Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis. J Neurosci Res 2005; 80:301-308
39. Bakshi R, Miletich RS, Kinkel PR, Emmet ML, Kinkel WR: High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging 1998; 8:228-234
40. 18F-fluorodeoxyglucose positron emission tomography study. Neurology 1997; 48:1566-1571
41. Ludwin SK: The pathogenesis of multiple sclerosis: relating human pathology to experimental studies. J Neuropathol Exper Neurology 2006; 65:305-318
42. Lyons SA, Kettenmann H: Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglycemia injury in vitro. J Cereb Blood Flow Metab 1998; 18:521-530
43. Tengvar C, Johansson B, Sorensen J: Frontal lobe and cingulate cortical metabolic dysfunction in acquired akinetic mutism: a PET study of the interval form of carbon monoxide poisoning. Brain Inj 2004; 18:615-625
44. Reed LJ, Lasserson D, Marsden P, Stanhope N, Stevens T, Bello F, Kingsley D, Colchester A, Kopelman MD: FDG-PET findings in the Wernicke-Korsakoff syndrome. Cortex 2003; 39:1027-1045
45. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE Jr, Jones EG: Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 1996; 53:425-436
46. Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP, Potkin SG, Sandman CA, Bunney WE Jr, Jones EG: Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 1996; 16:19-30
47. Kirkpatrick B, Messias NC, Conley RR, Roberts RC: Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia. J Nerv Ment Dis 2003; 191:563-567
48. Anderson SA, Volk DW, Lewis DA: Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr Res 1996; 19:111-119
49. Beasley CL, Cotter DR, Everall IP: Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration. Mol Psychiatry 2002; 7:564-570
50. Nopoulos PC, Flaum M, Andreasen NC, Swayze VW: Gray matter heterotopias in schizophrenia. Psychiatry Res 1995; 61:11-14
51. Buchsbaum MS, Nenadic I, Hazlett EA, Spiegel-Cohen J, Fleischman MB, Akhavan A, Silverman JM, Siever LJ: Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr Res 2002; 54:141-150
52. Shihabuddin L, Buchsbaum M, Hazlett E, Silverman J, New A, Brickman A, Mitropoulou V, Nunn M, Fleischman M, Tang C, Siever L: Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry 2001; 58:877-884
53. Haznedar MM, Buchsbaum MS, Luu C, Hazlett EA, Siegel BV Jr, Lohr J, Wu J, Haier RJ, Bunney WE Jr: Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry 1997; 154:682-684
54. Hazlett EA, Buchsbaum MS, Kemether EM, Bloom R, Platholi J, Shihabuddin L, Tang C, Byne W: Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Am J Psychiatry 2004; 161:305-314
55. Andreasen N, O'Leary D, Flaum M, Nopoulos P, Watkins G, Boles-Ponto L, Hichwa R: Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 1997; 349:1730-1734
56. Buchsbaum MS, Hazlett EA: Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull 1998; 24:343-364
57. Soyka M, Koch W, Möller HJ, Rüther T, Tatsch K: Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients: results from a FDG-PET study. Eur Arch Psychiatry Clin Neurosci 2005; 255:308-312
58. Volkow ND, Brodie JD, Wolf AP, Angrist B, Russell J, Cancro R: Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. J Neurol Neurosurg Psychiatry 1986; 49:1199-1202